Keeping Track: Veklury NDA Arrives At US FDA; Olinvyk Sees Approval; MAb Filings By Regneron, Y-mAbs

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
Novel Opioid agonist Olinvyk Restricted To ‘Controlled Clinical Settings’

More from US FDA Performance Tracker

More from Regulatory Trackers